Assessment of Left Atrial Fibrosis With Cardiac MRI
Monique Bernard

Abstract
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsCardiac Imaging and Diagnostics · Atrial Fibrillation Management and Outcomes · Cardiac Valve Diseases and Treatments
1
Atrial fibrillation (AF) is the most common sustained arrhythmia. AF is associated with an increased risk of thromboembolic stroke, heart failure with both an increased morbidity and mortality, and increasing worldwide prevalence [1]. AF is associated with structural, electrical, and functional alterations of the left atrium [2]. Left atrial (LA) fibrosis is a central component of structural remodeling and plays a major role in the pathogenesis and progression of atrial fibrillation [3]. LA fibrosis burden is used to assign the degree of LA fibrosis into 4 quartiles (Utah stages) [4]. Radiofrequency catheter ablation via pulmonary vein isolation (PVI) or pharmaceutical therapy is commonly used to treat AF depending on the fibrosis stage [5]. Assessing accurately the extent of fibrosis is therefore important for treatment stratification [6].
While histopathology is the reference standard, atrial fibrosis can be assessed with late gadolinium enhancement (LGE) MRI or with invasive electroanatomic voltage mapping (EAVM) [7]. Several studies have compared LGE MRI and EAVM, and the level of agreement has been shown to be dependent on acquisition and post‐processing parameters [8] or on the level of atrial cardiomyopathy severity [7] emphasizing the need for parameter harmonization.
3D late gadolinium‐enhanced (3D‐LGE) sequence provides high‐resolution images to identify LA fibrosis. Different image processing and fibrosis quantification methods can be used to quantify LA fibrosis using 3D‐LGE, based on open‐source or commercial software packages [6, 9, 10]. After performing segmentation or using computational left atria models [10] the most commonly used approaches are based on thresholding, and two of these methods are mostly used [9]. The SD method defines a number of standard deviations (SDs) above a reference value, usually the mean signal intensity for normal myocardium or mean signal intensity of the LA blood pool. A threshold of two or three SDs above the mean blood pool signal intensity is generally proposed using the SD method [9]. On the other hand, the image intensity ratio (IIR) method normalizes the signal intensity of the LA wall to the mean blood pool signal intensity. Thresholds of 0.97, 1.2, or 1.32 are generally used to indicate fibrosis [9, 10].
Studies show that atrial fibrotic burden is dependent on the post‐processing method used as well as on the defined threshold [7, 9]. Comparison of different threshold values and various post‐processing software as well as validation in large cohorts and multicenter studies and validation against histopathological data or mapping methods are needed to harmonize practices for LA fibrosis quantification using LGE.
The reference list from the paper itself. Each links out to its DOI / PubMed record.
- 1R. B. Schnabel , X. Yin , P. Gona , et al., “50 Year Trends in Atrial Fibrillation Prevalence, Incidence, Risk Factors, and Mortality in the Framingham Heart Study: A Cohort Study,” Lancet 386 (2015): 154–162.25960110 10.1016/S 0140-6736(14)61774-8PMC 4553037 · doi ↗ · pubmed ↗
- 2A. Goette , J. M. Kalman , L. Aguinaga , et al., “EHRA/HRS/APHRS/SOLAECE Expert Consensus on Atrial Cardiomyopathies: Definition, Characterization, and Clinical Implication,” Heart Rhythm 14 (2017): e 3–e 40.27320515 10.1016/j.hrthm.2016.05.028PMC 5548137 · doi ↗ · pubmed ↗
- 3S. Miyauchi , T. Tokuyama , S. Takahashi , et al., “Relationship Between Fibrosis, Endocardial Endothelial Damage, and Thrombosis of Left Atrial Appendage in Atrial Fibrillation,” JACC: Clinical Electrophysiology 9 (2023): 1158–1168.37495324 10.1016/j.jacep.2023.01.029 · doi ↗ · pubmed ↗
- 4N. Akoum , M. Daccarett , C. Mc Gann , et al., “Atrial Fibrosis Helps Select the Appropriate Patient and Strategy in Catheter Ablation of Atrial Fibrillation:A DE‐MRI Guided Approach,” Journal of Cardiovascular Electrophysiology 22, no. 1 (2011): 16–22.20807271 10.1111/j.1540-8167.2010.01876.x PMC 3133570 · doi ↗ · pubmed ↗
- 5J. Siebermair , E. G. Kholmovski , and N. Marrouche , “Assessment of Left Atrial Fibrosis by Late Gadolinium Enhancement Magnetic Resonance Imaging: Methodology and Clinical Implications,” JACC. Clinical Electrophysiology 3, no. 8 (2017): 791–802.29759774 10.1016/j.jacep.2017.07.004 · doi ↗ · pubmed ↗
- 6L. Li , V. A. Zimmer , J. A. Schnabel , and X. Zhuang , “Medical Image Analysis on Left Atrial LGE MRI for Atrial Fibrillation Studies: A Review,” Medical Image Analysis 77 (2022): 102360.35124370 10.1016/j.media.2022.102360 PMC 7614005 · doi ↗ · pubmed ↗
- 7I. Sim , J. A. S. Solis‐Lemus , C. O'Shea , et al., “Quantification of Atrial Cardiomyopathy Disease Severity by Electroanatomic Voltage Mapping and Cardiac Magnetic Resonance Imaging,” Journal of Cardiovascular Electrophysiology 36, no. 2 (2025): 467–479.39739521 10.1111/jce.16462 PMC 11837893 · doi ↗ · pubmed ↗
- 8G. P. Bijvoet , H. M. J. M. Nies , R. J. Holtackers , et al., “Correlation Between Cardiac MRI and Voltage Mapping in Evaluating Atrial Fibrosis: A Systematic Review. Radiol Cardiothorac,” Imaging 4, no. 5 (2022): e 220061.10.1148/ryct.220061 PMC 962723636339060 · doi ↗ · pubmed ↗
